Characteristic | (N = 900) |
---|---|
Proportion female | 63% |
Mean age (years) | 49.1 |
Mean BMI (kg/m2) | 36.4 |
Comorbidities (mean) | 1.8 per patient |
Cardiovascular (N = 449) | 50% |
Hypertension | 67% |
Dyslipidemia | 88% |
Major adverse cardiovascular events | 8% |
Metabolic (N = 442) | 49% |
Diabetes | 65% |
Polycystic ovary syndrome [PCOS], | 14% |
Non-alcoholic fatty liver disease [NAFLD] | 31% |
Gout | 7% |
Hypothyroidism | 20% |
Mental health (N = 292) | 33% |
Depression | 74% |
Anxiety | 64% |
Binge-eating disorder | 20% |
Attention deficit–hyperactivity disorder [ADHD] | 9% |
Other obesity-related comorbidities (N = 373) | 41% |
Osteoarthritis [OA] | 63% |
Obstructive sleep apnea [OSA] | 42% |
Gastroesophageal reflux disease [GERD] | 43% |
Urinary issues | 10% |
None | 10% |
Reason for appointment | |
Obesity-related complication | 38% |
Focus on weight | 33% |
Acute condition | 19% |
Other | 10% |